N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)-3-(4-(dimethylamino)but-2-enamido)cyclohexanecarboxamide

ID: ALA4760726

Chembl Id: CHEMBL4760726

PubChem CID: 145749876

Max Phase: Preclinical

Molecular Formula: C24H35N5O3S2

Molecular Weight: 505.71

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CN(C)C/C=C/C(=O)NC1CCCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1

Standard InChI:  InChI=1S/C24H35N5O3S2/c1-24(2,3)18-13-25-20(32-18)15-33-21-14-26-23(34-21)28-22(31)16-8-6-9-17(12-16)27-19(30)10-7-11-29(4)5/h7,10,13-14,16-17H,6,8-9,11-12,15H2,1-5H3,(H,27,30)(H,26,28,31)/b10-7+

Standard InChI Key:  HRIWKLDMFRXZJS-JXMROGBWSA-N

Alternative Forms

1. Parent:

   

   ALA4760726

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 505.71

Molecular Weight (Monoisotopic): 505.2181

AlogP: 4.45

#Rotatable Bonds: 9

Polar Surface Area: 100.36

Molecular Species: BASE

HBA: 8

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 7.90

CX Basic pKa: 8.86

CX LogP: 2.14

CX LogD: 1.79

Aromatic Rings: 2

Heavy Atoms: 34

QED Weighted: 0.38

Np Likeness Score: -1.22

References

1.  (2020)  Inhibitors of cyclin-dependent kinases, 

Source

Source(1):

• Patent Bioactivity Data